Japan based Mitsui & Company has made a strategic investment in Avon Organics’ parent company - Arch Pharmalabs (Arch) through a secondary market transaction, whereby the Japanese company has purchased 27.29% equity capital of Arch from private equity investors.
The transaction has been completed on January 16, 2013. Subsequent to which Mitsui & Company’s shareholding in Arch has increased from 4.67% to 31.96%.
Arch presently hold 63.60% equity capital of Avon Organics thereby making it a subsidiary company. However, there is no change envisaged/contemplated in the control and management of Arch Pharmalabs and/or at Avon Organics, pursuant to strategic investment by Mistui & Company in Arch.
